Lorediplon: Completed Phase IIa enrollment

Ergomed completed enrollment of >=130 adult insomniacs in a double-blind, placebo-controlled, crossover, international Phase IIa

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE